ADA2024-话题@MedSci

#ADA2024#

0篇内容 | 612人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2211554, encodeId=9806221155498, content=<a href='/topic/show?id=890e8438e3e' target=_blank style='color:#2F92EE;'>#脂肪肝#</a> <a href='/topic/show?id=f4c251404aa' target=_blank style='color:#2F92EE;'>#心脏代谢#</a> <a href='/topic/show?id=e88a10494435' target=_blank style='color:#2F92EE;'>#Mazdutide#</a> <a href='/topic/show?id=1e95115803e7' target=_blank style='color:#2F92EE;'>#ADA2024#</a>, objectTitle=“一箭三雕”！新药不仅减重、消除脂肪肝，还可改善心脏代谢风险 | ADA 2024速递, objectType=article, longId=831617, objectId=002b83161e80, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240625/1719283693072_5579292.jpg, objectUrl=/article/show_article.do?id=002b83161e80, replyNumber=0, likeNumber=0, createdTime=2024-06-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=002b83161e80, moduleTitle=“一箭三雕”！新药不仅减重、消除脂肪肝，还可改善心脏代谢风险 | ADA 2024速递, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=002b83161e80)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211559, encodeId=5aa32211559ff, content=<a href='/topic/show?id=3ad9818917c' target=_blank style='color:#2F92EE;'>#肥胖#</a> <a href='/topic/show?id=1e95115803e7' target=_blank style='color:#2F92EE;'>#ADA2024#</a> <a href='/topic/show?id=864711585ea0' target=_blank style='color:#2F92EE;'>#Utreglutide#</a>, objectTitle=1个月体重减少近10斤！新药带来亮眼减重效果 | ADA 2024速递, objectType=article, longId=831591, objectId=fe6383159177, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240625/1719293701323_92910.jpg, objectUrl=/article/show_article.do?id=fe6383159177, replyNumber=0, likeNumber=113, createdTime=2024-06-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fe6383159177, moduleTitle=1个月体重减少近10斤！新药带来亮眼减重效果 | ADA 2024速递, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe6383159177)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211375, encodeId=789b22113e57e, content=<a href='/topic/show?id=0c08e663070' target=_blank style='color:#2F92EE;'>#糖化血红蛋白#</a> <a href='/topic/show?id=e2be104e2649' target=_blank style='color:#2F92EE;'>#司美格鲁肽#</a> <a href='/topic/show?id=1e95115803e7' target=_blank style='color:#2F92EE;'>#ADA2024#</a>, objectTitle=助力患者糖化血红蛋白达标！司美格鲁肽效用更优 | ADA 2024速递, objectType=article, longId=831463, objectId=0f72831463db, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719199290885_5579292.jpg, objectUrl=/article/show_article.do?id=0f72831463db, replyNumber=0, likeNumber=107, createdTime=2024-06-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0f72831463db, moduleTitle=助力患者糖化血红蛋白达标！司美格鲁肽效用更优 | ADA 2024速递, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f72831463db)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211391, encodeId=dc07221139107, content=<a href='/topic/show?id=d20f1090c2' target=_blank style='color:#2F92EE;'>#2型糖尿病#</a> <a href='/topic/show?id=bb0e8081b2' target=_blank style='color:#2F92EE;'>#GLP-1受体激动剂#</a> <a href='/topic/show?id=1e95115803e7' target=_blank style='color:#2F92EE;'>#ADA2024#</a> <a href='/topic/show?id=10e011581471' target=_blank style='color:#2F92EE;'>#ZT002#</a>, objectTitle=每月一次，减重效果维持71天！GLP-1新药效果积极 | ADA 2024速递, objectType=article, longId=831444, objectId=761983144449, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719199471466_5579292.png, objectUrl=/article/show_article.do?id=761983144449, replyNumber=0, likeNumber=85, createdTime=2024-06-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=761983144449, moduleTitle=每月一次，减重效果维持71天！GLP-1新药效果积极 | ADA 2024速递, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=761983144449)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

糖化血红蛋白司美格鲁肽 ADA2024

2024-06-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#脂肪肝# #心脏代谢# #Mazdutide# #ADA2024#

“一箭三雕”！新药不仅减重、消除脂肪肝，还可改善心脏代谢风险 | ADA 2024速递

2024-06-25发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肥胖# #ADA2024# #Utreglutide#

1个月体重减少近10斤！新药带来亮眼减重效果 | ADA 2024速递

2024-06-25发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#糖化血红蛋白# #司美格鲁肽# #ADA2024#

助力患者糖化血红蛋白达标！司美格鲁肽效用更优 | ADA 2024速递

2024-06-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#2型糖尿病# #GLP-1受体激动剂# #ADA2024# #ZT002#

每月一次，减重效果维持71天！GLP-1新药效果积极 | ADA 2024速递

2024-06-24发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务